Summit Therapeutics Inc. (SMMT)
CIK 1599298 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Summit Therapeutics Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 3, 2026 | 8-K | 0001599298-26-000076 |
| Aug 26, 2026 | 8-K | 0001599298-26-000074 |
| Aug 5, 2026 | 8-K | 0001599298-26-000071 |
| Jul 23, 2026 | 8-K | 0001193125-26-314214 |
| Jul 23, 2026 | 424B5 | 0001193125-26-314210 |
| Jul 23, 2026 | 10-Q | 0001599298-26-000068 |
| Jul 23, 2026 | 8-K | 0001599298-26-000067 |
| Jul 22, 2026 | 8-K | 0001599298-26-000058 |
| Jun 12, 2026 | 4 | 0001507650-26-000007 |
| Jun 12, 2026 | 8-K | 0001599298-26-000054 |
| Jun 12, 2026 | 4 | 0001055919-26-000007 |
| Jun 11, 2026 | 8-K | 0001599298-26-000052 |
| Jun 10, 2026 | 424B5 | 0001193125-26-264471 |
| Jun 9, 2026 | S-3ASR | 0001193125-26-263861 |
| Jun 4, 2026 | 4 | 0001507650-26-000005 |
| Jun 4, 2026 | 4 | 0001569769-26-000004 |
| Jun 4, 2026 | 4 | 0001055919-26-000005 |
| Jun 3, 2026 | 8-K | 0001599298-26-000049 |
| Jun 1, 2026 | 8-K | 0001599298-26-000043 |
| Apr 30, 2026 | 10-Q | 0001599298-26-000039 |
| Apr 30, 2026 | 8-K | 0001599298-26-000037 |
| Apr 17, 2026 | DEFA14A | 0001599298-26-000033 |
| Apr 17, 2026 | ARS | 0001599298-26-000030 |
| Apr 17, 2026 | DEF 14A | 0001599298-26-000029 |
| Apr 6, 2026 | PRE 14A | 0001599298-26-000021 |